GHRP-6 10 mg

GHRP-6 10 mg contains growth hormone releasing peptide-6, a ghrelin receptor agonist. In research settings it is used to stimulate GH release. In non-medical bodybuilding contexts, GHRP-6 is commonly referenced for its GH-stimulating properties and pronounced appetite stimulation, though such use falls outside approved indications.

Community protocols commonly reference GHRP-6 being injected 2–3 times daily at doses of 100–300 mcg per injection. Doses are typically timed on an empty stomach to maximize the GH response. The GH pulse from GHRP-6 is short-lived, which is why multiple daily doses are used to create multiple pulses.

GHRP-6 does not suppress endogenous testosterone production because it acts on the ghrelin receptor rather than directly affecting the hypothalamic-pituitary-gonadal axis. Post-cycle therapy is therefore generally not considered necessary after GHRP-6 use alone.

GHRP-6 stimulates growth hormone release by activating the ghrelin receptor (GHS-R1a) in the pituitary and hypothalamus. This produces a pulsatile GH release that mimics the body's natural secretion pattern. GHRP-6 also produces pronounced appetite stimulation and moderate elevations in cortisol and prolactin.

The GH pulse from a single GHRP-6 injection typically peaks within 15–30 minutes and returns to baseline within a few hours. Appetite stimulation begins within 15–20 minutes and lasts 1–2 hours. Any cumulative effects on physique or recovery would develop over weeks of consistent use.

There is no single GH secretagogue that is universally best. GHRP-6 is the original GHRP and produces the most pronounced appetite stimulation. GHRP-2 offers comparable GH release with less appetite effect, while Ipamorelin is more selective with minimal cortisol and prolactin effects. The appropriate choice depends on individual goals.

Both GHRP-6 and GHRP-2 are growth hormone secretagogues that act on the ghrelin receptor. The main practical difference is that GHRP-6 produces significantly more appetite stimulation, while GHRP-2 has a more moderate effect. GHRP-6 also tends to produce slightly greater cortisol elevation at equivalent doses.

GHRP-6 is more potent for GH release but less selective, producing pronounced appetite stimulation and moderate cortisol and prolactin elevations. Ipamorelin is more selective with minimal effects on these hormones but produces a smaller GH pulse. GHRP-6 is positioned at the less selective end of the GHRP spectrum.

100 mcg is commonly referenced as the saturation dose for GHRP-6, meaning the point beyond which additional peptide produces diminishing GH response. Doses of 100–300 mcg per injection are typical in community protocols. The 10 mg vial contains 10,000 mcg total, providing 33–100 doses at these levels.

GHRP-6 10 mg is labeled at 10 mg of GHRP-6 per vial. It is supplied as a lyophilized powder in a 2 mL vial, requiring reconstitution before use.

Yes. A published laboratory report dated November 7, 2025 measured GHRP-6 10 mg at 10.38 mg, equivalent to 103.8% of its 10 mg label claim. The batch number for this report is #HDGH10.

The complete report can be viewed in the Lab Reports tab. Laboratory results apply to the tested sample represented by the individual report and should not be interpreted as a measurement of every vial.

Lyophilized GHRP-6 is typically reconstituted with a suitable solvent such as Bacteriostatic Water or sterile water. The volume of solvent added determines the concentration of the resulting solution. Proper sterile technique should be used during reconstitution.